AM Pharma

Inotrem

This biopharmaceutical company develops immunotherapies targeting the TREM-1 pathway for patients suffering from acute inflammatory syndromes such as septic shock.

Adrenomed

This biopharmaceutical company develops monoclonal antibody therapies to restore vascular integrity for critically ill patients suffering from sepsis and septic shock.

Amplifier Therapeutics

This biopharmaceutical company develops AMP-activated protein kinase activator compounds to treat patients with cardiometabolic, kidney and other age-related diseases.

Pathalys Pharma

This biopharmaceutical company develops treatments for secondary hyperparathyroidism in patients with end-stage kidney disease undergoing dialysis.

Alpine Immune Sciences

This biopharmaceutical company develops protein-based immunotherapies to treat autoimmune and inflammatory diseases for patients with conditions like kidney disease.

Matisse Pharmaceuticals B.V.

This biopharmaceutical company develops heparin-derived medicinal therapies to treat sepsis and septic shock for patients in intensive care units.

ABIONYX Pharma

The company develops recombinant HDL-based biotherapies for patients with sepsis, renal diseases, and ophthalmological conditions.

Hemotune

This company develops a magnetic blood purification platform using nanoengineered beads to remove specific disease-causing substances for patients with sepsis or requiring gene therapy.